2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow PankoMab-GEX: new trials by email Literature Review of PankoMab-GEX trials Research Report on PankoMab-GEX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors First part: Gatipotuzumab and Tomuzotuximab; Second part: Gatipotuzumab and Tomuzotuximab or anti-EGFR antibody (Cetuximab, Panitumumab or Necitumumab) - Solid Tumor, Adult | Phase 1 | Completed | Glycotope GmbH | 50 | 2017-11-02 | 2021-07-12 |
| PankoMab-GEX™: Phase 1 Dose Escalation Study PankoMab-GEX™ - Solid Tumors | Phase 1 | Completed | Glycotope GmbH | 74 | 2009-11-01 | 2021-05-20 |
Glycotope GmbH (2)
Germany (2) · Italy (2) · Spain (1) · Switzerland (1)
Sebastian Ochsenreither, Dr. med. (1)
2017 (1)